aluates Reports

$ 0.0

Automative

Global Generic Anti-cancer Injectables Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-28T10537

Global Generic Anti cancer Injectables Market Research Report 2022

BUY CHAPTERS

Global Generic Anti-cancer Injectables Market Research Report 2025

Code: QYRE-Auto-28T10537

Report

February 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

TEVA

Viatris

Biocon Ltd.

Amgen Inc

Sandoz(Novartis)

Pfizer Inc

Qilu Pharmaceutical

CTTQ

Jiangsu Hengrui

CSPC

Innovent Biologics

Jiangsu Hansoh

Generic Anti-cancer Injectables Market

The global market for Generic Anti-cancer Injectables was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Generic Anti-cancer Injectables is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Generic Anti-cancer Injectables is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Generic Anti-cancer Injectables in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Generic Anti-cancer Injectables include Teva, Viatris, Biocon, Amgen, Sandoz (Novartis), Pfizer, Qilu Pharmaceutical, Jiangsu Hansoh, CTTQ, Jiangsu Hengrui, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Generic Anti-cancer Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Anti-cancer Injectables.

The Generic Anti-cancer Injectables market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Generic Anti-cancer Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Generic Anti-cancer Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Generic Anti-cancer Injectables Market Report

Report Metric	Details
Report Name	Generic Anti-cancer Injectables Market
Segment by Type	Bevacizuma Rituximab Herceptin Paclitaxel Others
Segment by Application	Hospital Retail
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Viatris, Biocon, Amgen, Sandoz (Novartis), Pfizer, Qilu Pharmaceutical, Jiangsu Hansoh, CTTQ, Jiangsu Hengrui, CSPC, Innovent Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Anti-cancer Injectables company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Generic Anti-cancer Injectables Market report?

Ans: The main players in the Generic Anti-cancer Injectables Market are Teva, Viatris, Biocon, Amgen, Sandoz (Novartis), Pfizer, Qilu Pharmaceutical, Jiangsu Hansoh, CTTQ, Jiangsu Hengrui, CSPC, Innovent Biologics

What are the Application segmentation covered in the Generic Anti-cancer Injectables Market report?

Ans: The Applications covered in the Generic Anti-cancer Injectables Market report are Hospital, Retail

What are the Type segmentation covered in the Generic Anti-cancer Injectables Market report?

Ans: The Types covered in the Generic Anti-cancer Injectables Market report are Bevacizuma, Rituximab, Herceptin, Paclitaxel, Others

Recommended Reports

Cancer Therapeutics

Oncology Drug Markets

Injectables & Generics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Generic Anti-cancer Injectables Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Bevacizuma

1.2.3 Rituximab

1.2.4 Herceptin

1.2.5 Paclitaxel

1.2.6 Others

1.3 Market by Application

1.3.1 Global Generic Anti-cancer Injectables Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Generic Anti-cancer Injectables Market Perspective (2020-2031)

2.2 Global Generic Anti-cancer Injectables Growth Trends by Region

2.2.1 Global Generic Anti-cancer Injectables Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Generic Anti-cancer Injectables Historic Market Size by Region (2020-2025)

2.2.3 Generic Anti-cancer Injectables Forecasted Market Size by Region (2026-2031)

2.3 Generic Anti-cancer Injectables Market Dynamics

2.3.1 Generic Anti-cancer Injectables Industry Trends

2.3.2 Generic Anti-cancer Injectables Market Drivers

2.3.3 Generic Anti-cancer Injectables Market Challenges

2.3.4 Generic Anti-cancer Injectables Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Generic Anti-cancer Injectables Players by Revenue

3.1.1 Global Top Generic Anti-cancer Injectables Players by Revenue (2020-2025)

3.1.2 Global Generic Anti-cancer Injectables Revenue Market Share by Players (2020-2025)

3.2 Global Generic Anti-cancer Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Generic Anti-cancer Injectables Revenue

3.4 Global Generic Anti-cancer Injectables Market Concentration Ratio

3.4.1 Global Generic Anti-cancer Injectables Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Generic Anti-cancer Injectables Revenue in 2024

3.5 Global Key Players of Generic Anti-cancer Injectables Head office and Area Served

3.6 Global Key Players of Generic Anti-cancer Injectables, Product and Application

3.7 Global Key Players of Generic Anti-cancer Injectables, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Anti-cancer Injectables Breakdown Data by Type

4.1 Global Generic Anti-cancer Injectables Historic Market Size by Type (2020-2025)

4.2 Global Generic Anti-cancer Injectables Forecasted Market Size by Type (2026-2031)

5 Generic Anti-cancer Injectables Breakdown Data by Application

5.1 Global Generic Anti-cancer Injectables Historic Market Size by Application (2020-2025)

5.2 Global Generic Anti-cancer Injectables Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Generic Anti-cancer Injectables Market Size (2020-2031)

6.2 North America Generic Anti-cancer Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Generic Anti-cancer Injectables Market Size by Country (2020-2025)

6.4 North America Generic Anti-cancer Injectables Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Generic Anti-cancer Injectables Market Size (2020-2031)

7.2 Europe Generic Anti-cancer Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Generic Anti-cancer Injectables Market Size by Country (2020-2025)

7.4 Europe Generic Anti-cancer Injectables Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Generic Anti-cancer Injectables Market Size (2020-2031)

8.2 Asia-Pacific Generic Anti-cancer Injectables Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Generic Anti-cancer Injectables Market Size by Region (2020-2025)

8.4 Asia-Pacific Generic Anti-cancer Injectables Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Generic Anti-cancer Injectables Market Size (2020-2031)

9.2 Latin America Generic Anti-cancer Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Generic Anti-cancer Injectables Market Size by Country (2020-2025)

9.4 Latin America Generic Anti-cancer Injectables Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Generic Anti-cancer Injectables Market Size (2020-2031)

10.2 Middle East & Africa Generic Anti-cancer Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Generic Anti-cancer Injectables Market Size by Country (2020-2025)

10.4 Middle East & Africa Generic Anti-cancer Injectables Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Details

11.1.2 Teva Business Overview

11.1.3 Teva Generic Anti-cancer Injectables Introduction

11.1.4 Teva Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.1.5 Teva Recent Development

11.2 Viatris

11.2.1 Viatris Company Details

11.2.2 Viatris Business Overview

11.2.3 Viatris Generic Anti-cancer Injectables Introduction

11.2.4 Viatris Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.2.5 Viatris Recent Development

11.3 Biocon

11.3.1 Biocon Company Details

11.3.2 Biocon Business Overview

11.3.3 Biocon Generic Anti-cancer Injectables Introduction

11.3.4 Biocon Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.3.5 Biocon Recent Development

11.4 Amgen

11.4.1 Amgen Company Details

11.4.2 Amgen Business Overview

11.4.3 Amgen Generic Anti-cancer Injectables Introduction

11.4.4 Amgen Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.4.5 Amgen Recent Development

11.5 Sandoz (Novartis)

11.5.1 Sandoz (Novartis) Company Details

11.5.2 Sandoz (Novartis) Business Overview

11.5.3 Sandoz (Novartis) Generic Anti-cancer Injectables Introduction

11.5.4 Sandoz (Novartis) Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.5.5 Sandoz (Novartis) Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Generic Anti-cancer Injectables Introduction

11.6.4 Pfizer Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Qilu Pharmaceutical

11.7.1 Qilu Pharmaceutical Company Details

11.7.2 Qilu Pharmaceutical Business Overview

11.7.3 Qilu Pharmaceutical Generic Anti-cancer Injectables Introduction

11.7.4 Qilu Pharmaceutical Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.7.5 Qilu Pharmaceutical Recent Development

11.8 Jiangsu Hansoh

11.8.1 Jiangsu Hansoh Company Details

11.8.2 Jiangsu Hansoh Business Overview

11.8.3 Jiangsu Hansoh Generic Anti-cancer Injectables Introduction

11.8.4 Jiangsu Hansoh Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.8.5 Jiangsu Hansoh Recent Development

11.9 CTTQ

11.9.1 CTTQ Company Details

11.9.2 CTTQ Business Overview

11.9.3 CTTQ Generic Anti-cancer Injectables Introduction

11.9.4 CTTQ Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.9.5 CTTQ Recent Development

11.10 Jiangsu Hengrui

11.10.1 Jiangsu Hengrui Company Details

11.10.2 Jiangsu Hengrui Business Overview

11.10.3 Jiangsu Hengrui Generic Anti-cancer Injectables Introduction

11.10.4 Jiangsu Hengrui Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.10.5 Jiangsu Hengrui Recent Development

11.11 CSPC

11.11.1 CSPC Company Details

11.11.2 CSPC Business Overview

11.11.3 CSPC Generic Anti-cancer Injectables Introduction

11.11.4 CSPC Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.11.5 CSPC Recent Development

11.12 Innovent Biologics

11.12.1 Innovent Biologics Company Details

11.12.2 Innovent Biologics Business Overview

11.12.3 Innovent Biologics Generic Anti-cancer Injectables Introduction

11.12.4 Innovent Biologics Revenue in Generic Anti-cancer Injectables Business (2020-2025)

11.12.5 Innovent Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

TEVA

Viatris

Biocon Ltd.

Amgen Inc

Sandoz(Novartis)

Pfizer Inc

Qilu Pharmaceutical

CTTQ

Jiangsu Hengrui

CSPC

Innovent Biologics

Jiangsu Hansoh

List of Tables

Table 1. Global Generic Anti-cancer Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Bevacizuma

Table 3. Key Players of Rituximab

Table 4. Key Players of Herceptin

Table 5. Key Players of Paclitaxel

Table 6. Key Players of Others

Table 7. Global Generic Anti-cancer Injectables Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Generic Anti-cancer Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Generic Anti-cancer Injectables Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Generic Anti-cancer Injectables Market Share by Region (2020-2025)

Table 11. Global Generic Anti-cancer Injectables Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Generic Anti-cancer Injectables Market Share by Region (2026-2031)

Table 13. Generic Anti-cancer Injectables Market Trends

Table 14. Generic Anti-cancer Injectables Market Drivers

Table 15. Generic Anti-cancer Injectables Market Challenges

Table 16. Generic Anti-cancer Injectables Market Restraints

Table 17. Global Generic Anti-cancer Injectables Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Generic Anti-cancer Injectables Market Share by Players (2020-2025)

Table 19. Global Top Generic Anti-cancer Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Anti-cancer Injectables as of 2024)

Table 20. Ranking of Global Top Generic Anti-cancer Injectables Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Generic Anti-cancer Injectables Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Generic Anti-cancer Injectables, Headquarters and Area Served

Table 23. Global Key Players of Generic Anti-cancer Injectables, Product and Application

Table 24. Global Key Players of Generic Anti-cancer Injectables, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Generic Anti-cancer Injectables Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Generic Anti-cancer Injectables Revenue Market Share by Type (2020-2025)

Table 28. Global Generic Anti-cancer Injectables Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Generic Anti-cancer Injectables Revenue Market Share by Type (2026-2031)

Table 30. Global Generic Anti-cancer Injectables Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Generic Anti-cancer Injectables Revenue Market Share by Application (2020-2025)

Table 32. Global Generic Anti-cancer Injectables Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Generic Anti-cancer Injectables Revenue Market Share by Application (2026-2031)

Table 34. North America Generic Anti-cancer Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Generic Anti-cancer Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Generic Anti-cancer Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Generic Anti-cancer Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Generic Anti-cancer Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Generic Anti-cancer Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Generic Anti-cancer Injectables Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Generic Anti-cancer Injectables Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Generic Anti-cancer Injectables Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Generic Anti-cancer Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Generic Anti-cancer Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Generic Anti-cancer Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Generic Anti-cancer Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Generic Anti-cancer Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Generic Anti-cancer Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 49. Teva Company Details

Table 50. Teva Business Overview

Table 51. Teva Generic Anti-cancer Injectables Product

Table 52. Teva Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 53. Teva Recent Development

Table 54. Viatris Company Details

Table 55. Viatris Business Overview

Table 56. Viatris Generic Anti-cancer Injectables Product

Table 57. Viatris Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 58. Viatris Recent Development

Table 59. Biocon Company Details

Table 60. Biocon Business Overview

Table 61. Biocon Generic Anti-cancer Injectables Product

Table 62. Biocon Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 63. Biocon Recent Development

Table 64. Amgen Company Details

Table 65. Amgen Business Overview

Table 66. Amgen Generic Anti-cancer Injectables Product

Table 67. Amgen Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 68. Amgen Recent Development

Table 69. Sandoz (Novartis) Company Details

Table 70. Sandoz (Novartis) Business Overview

Table 71. Sandoz (Novartis) Generic Anti-cancer Injectables Product

Table 72. Sandoz (Novartis) Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 73. Sandoz (Novartis) Recent Development

Table 74. Pfizer Company Details

Table 75. Pfizer Business Overview

Table 76. Pfizer Generic Anti-cancer Injectables Product

Table 77. Pfizer Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 78. Pfizer Recent Development

Table 79. Qilu Pharmaceutical Company Details

Table 80. Qilu Pharmaceutical Business Overview

Table 81. Qilu Pharmaceutical Generic Anti-cancer Injectables Product

Table 82. Qilu Pharmaceutical Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 83. Qilu Pharmaceutical Recent Development

Table 84. Jiangsu Hansoh Company Details

Table 85. Jiangsu Hansoh Business Overview

Table 86. Jiangsu Hansoh Generic Anti-cancer Injectables Product

Table 87. Jiangsu Hansoh Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 88. Jiangsu Hansoh Recent Development

Table 89. CTTQ Company Details

Table 90. CTTQ Business Overview

Table 91. CTTQ Generic Anti-cancer Injectables Product

Table 92. CTTQ Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 93. CTTQ Recent Development

Table 94. Jiangsu Hengrui Company Details

Table 95. Jiangsu Hengrui Business Overview

Table 96. Jiangsu Hengrui Generic Anti-cancer Injectables Product

Table 97. Jiangsu Hengrui Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 98. Jiangsu Hengrui Recent Development

Table 99. CSPC Company Details

Table 100. CSPC Business Overview

Table 101. CSPC Generic Anti-cancer Injectables Product

Table 102. CSPC Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 103. CSPC Recent Development

Table 104. Innovent Biologics Company Details

Table 105. Innovent Biologics Business Overview

Table 106. Innovent Biologics Generic Anti-cancer Injectables Product

Table 107. Innovent Biologics Revenue in Generic Anti-cancer Injectables Business (2020-2025) & (US$ Million)

Table 108. Innovent Biologics Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Generic Anti-cancer Injectables Picture

Figure 2. Global Generic Anti-cancer Injectables Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Generic Anti-cancer Injectables Market Share by Type: 2024 VS 2031

Figure 4. Bevacizuma Features

Figure 5. Rituximab Features

Figure 6. Herceptin Features

Figure 7. Paclitaxel Features

Figure 8. Others Features

Figure 9. Global Generic Anti-cancer Injectables Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Generic Anti-cancer Injectables Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Retail Case Studies

Figure 13. Generic Anti-cancer Injectables Report Years Considered

Figure 14. Global Generic Anti-cancer Injectables Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Generic Anti-cancer Injectables Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Generic Anti-cancer Injectables Market Share by Region: 2024 VS 2031

Figure 17. Global Generic Anti-cancer Injectables Market Share by Players in 2024

Figure 18. Global Top Generic Anti-cancer Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Anti-cancer Injectables as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Generic Anti-cancer Injectables Revenue in 2024

Figure 20. North America Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Generic Anti-cancer Injectables Market Share by Country (2020-2031)

Figure 22. United States Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Generic Anti-cancer Injectables Market Share by Country (2020-2031)

Figure 26. Germany Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Generic Anti-cancer Injectables Market Share by Region (2020-2031)

Figure 34. China Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Generic Anti-cancer Injectables Market Share by Country (2020-2031)

Figure 42. Mexico Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Generic Anti-cancer Injectables Market Share by Country (2020-2031)

Figure 46. Turkey Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Generic Anti-cancer Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Teva Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 50. Viatris Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 51. Biocon Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 52. Amgen Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 53. Sandoz (Novartis) Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 55. Qilu Pharmaceutical Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 56. Jiangsu Hansoh Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 57. CTTQ Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 58. Jiangsu Hengrui Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 59. CSPC Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 60. Innovent Biologics Revenue Growth Rate in Generic Anti-cancer Injectables Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Generic Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Generics Market

Global Anti tumor Drug Market Research Report 2025

Global Generic Injectables for Infectious Diseases Market Research Report 2024

Global Anti VEGF Injection Market Research Report 2024

Anti Neoplastic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibodies in Oncology Market Research Report 2024

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Antibody Drug Conjugates Market Research Report 2024

Global Oncology Generic Injectable Drugs Market Research Report 2024

Breast Cancer Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Drugs for Multiple Cancers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oxaliplatin Injection Market Research Report 2024

Global Generic API Market Research Report 2025

Global Carboplatin Injection Market Research Report 2024

Global Cancer Diagnostic Kit Market Research Report 2024

Generic Sterile Injectable Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions